Showing 1 - 20 results of 23 for search 'Antonio Llombart', query time: 0.04s
Refine Results
-
1
-
2
Factores pronósticos clínicos, inmunohistoquímicos, clasificadores y eventos adversos determinantes en las metástasis a distancia en los carcinomas mamarios infiltrantes by Lissette Ruiz Jorge, Milagros Alegret Rodríguez, Isidro Machado Puerto, Antonio Llombart-Bosh
Published 2018-10-01
Article -
3
-
4
-
5
-
6
-
7
Solitary Fibrous Tumor: Integration of Clinical, Morphologic, Immunohistochemical and Molecular Findings in Risk Stratification and Classification May Better Predict Patient outcom... by Isidro Machado, María Gema Nieto Morales, Julia Cruz, Javier Lavernia, Francisco Giner, Samuel Navarro, Antonio Ferrandez, Antonio Llombart-Bosch
Published 2021-08-01
Article -
8
Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy by Beatriz Honrubia-Peris, Javier Garde-Noguera, Jose García-Sánchez, Nuria Piera-Molons, Antonio Llombart-Cussac, María Leonor Fernández-Murga
Published 2021-08-01
Article -
9
A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer by Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Andrea Malfettone, Elena López-Miranda, Elena López-Miranda, María Gion, Elena Abad, Daniel Alcalá-López, Jhudit Pérez-Escuredo, José Manuel Pérez-García, José Manuel Pérez-García, Antonio Llombart-Cussac, Antonio Llombart-Cussac, Javier Cortés, Javier Cortés, Javier Cortés
Published 2023-07-01
Article -
10
-
11
<i>ETV6::NTRK3</i> Fusion-Positive Wild-Type Gastrointestinal Stromal Tumor (GIST) with Abundant Lymphoid Infiltration (TILs and Tertiary Lymphoid Structures): A Report on a New Ca... by Isidro Machado, Reyes Claramunt-Alonso, Javier Lavernia, Ignacio Romero, María Barrios, María José Safont, Nuria Santonja, Lara Navarro, José Antonio López-Guerrero, Antonio Llombart-Bosch
Published 2024-03-01
Article -
12
Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling by Francisco Giner, Isidro Machado, Luis Alberto Rubio-Martínez, José Antonio López-Guerrero, Reyes Claramunt-Alonso, Samuel Navarro, Antonio Ferrández, Empar Mayordomo-Aranda, Antonio Llombart-Bosch
Published 2023-04-01
Article -
13
Evaluation of Alternative Risk Stratification Systems in a Large Series of Solitary Fibrous Tumors with Molecular Findings and Ki-67 Index Data: Do They Improve Risk Assessment? by Isidro Machado, Álvaro Blázquez Bujeda, Francisco Giner, María Gema Nieto Morales, Julia Cruz, Javier Lavernia, Samuel Navarro, Antonio Ferrandez, Amparo Ruiz-Sauri, Antonio Llombart-Bosch
Published 2022-12-01
Article -
14
Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer by José Manuel López-Vega, Isabel Álvarez, Antonio Antón, José Juan Illarramendi, Antonio Llombart, Valentina Boni, María José García-Velloso, Josep María Martí-Climent, Luis Pina, Jesús García-Foncillas
Published 2021-07-01
Article -
15
Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population by Javier Garde-Noguera, M. Leonor Fernández-Murga, Vicent Giner-Bosch, Victoria Dominguez-Márquez, José García Sánchez, Juan José Soler-Cataluña, Franscica López Chuliá, Beatriz Honrubia, Nuria Piera, Antonio Llombart-Cussac
Published 2020-11-01
Article -
16
Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study by Antonio Llombart-Cussac, Antonio Anton-Torres, Beatriz Rojas, Raquel Andrés, Noelia Martinez, César A. Rodríguez, Sara Marin, Teresa Puértolas, Alejandro Falcón González, María Leonor Fernández-Murga, Carlos Hagen, Manuel Ruiz-Borrego
Published 2023-02-01
Article -
17
Latent Microsporidia Infection Prevalence as a Risk Factor in Colon Cancer Patients by Fernando Redondo, Carolina Hurtado-Marcos, Fernando Izquierdo, Carmen Cuéllar, Soledad Fenoy, Yanira Sáez, Ángela Magnet, Lorena Galindo-Regal, Natalia Uribe, Manuel López-Bañeres, Ana Isabel Jiménez, Antonio Llombart-Cussac, Carmen Del Águila, Juan Carlos Andreu-Ballester
Published 2022-10-01
Article -
18
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial by Elena López-Miranda, José Manuel Pérez-García, Serena Di Cosimo, Etienne Brain, Maja Ravnik, Santiago Escrivá-de-Romaní, Maria Vidal, Joseph Gligorov, Simona Borštnar, Laura Calabuig, Miguel Sampayo-Cordero, Andrea Malfettone, Antonio Llombart-Cussac, Thomas M. Suter, Javier Cortés
Published 2020-11-01
Article -
19
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial by Tomás Pascual, Mafalda Oliveira, Patricia Villagrasa, Vanesa Ortega, Laia Paré, Begoña Bermejo, Serafín Morales, Kepa Amillano, Rafael López, Patricia Galván, Jordi Canes, Fernando Salvador, Paolo Nuciforo, Isabel T. Rubio, Antonio Llombart-Cussac, Serena Di Cosimo, José Baselga, Nadia Harbeck, Aleix Prat, Javier Cortés
Published 2021-11-01
Article -
20
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis by Sukanya Chakraborty, Aaqib M. Bhat, Insha Mushtaq, Haitao Luan, Achyuth Kalluchi, Sameer Mirza, Matthew D. Storck, Nagendra Chaturvedi, Jose Antonio Lopez-Guerrero, Antonio Llombart-Bosch, Isidro Machado, Katia Scotlandi, Jane L. Meza, Gargi Ghosal, Donald W. Coulter, M. Jordan Rowley, Vimla Band, Bhopal C. Mohapatra, Hamid Band
Published 2023-07-01
Article